CN1292659C - Biological disinfectant - Google Patents

Biological disinfectant Download PDF

Info

Publication number
CN1292659C
CN1292659C CNB200410022896XA CN200410022896A CN1292659C CN 1292659 C CN1292659 C CN 1292659C CN B200410022896X A CNB200410022896X A CN B200410022896XA CN 200410022896 A CN200410022896 A CN 200410022896A CN 1292659 C CN1292659 C CN 1292659C
Authority
CN
China
Prior art keywords
lactoferrin
disinfectant
chlorhexidine
present
distilled water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB200410022896XA
Other languages
Chinese (zh)
Other versions
CN1559218A (en
Inventor
袁洪
陽国平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB200410022896XA priority Critical patent/CN1292659C/en
Publication of CN1559218A publication Critical patent/CN1559218A/en
Application granted granted Critical
Publication of CN1292659C publication Critical patent/CN1292659C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to a biological disinfectant which is characterized in that the present invention is prepared from the raw materials according to the following weight percentage by the method, wherein the raw materials comprise 0.1 to 1% of lactoferrin and 0.001 to 0.01% of chlorhexidine, and the rest is distilled water; the preparation method comprises the steps: the 0.1 to 1% of lactoferrin is dissolved in the distilled water; in addition, the 0.001 to 0.01% of chlorhexidine is dissolved in the distilled water; thus, the disinfectant is obtained by mixing the two liquids. In the present invention, because the lactoferrin which is biological engineering product is added, the thickness of the chlorhexidine is greatly reduced; thus, the side effect on human body skins is reduced; antimicrobic effect is improved because of the synergistic effect from the lactoferrin and chlorhexidine.

Description

Biotype disinfectant and preparation method
Technical field:
The present invention relates to a kind of disinfectant, be specifically related to a kind of disinfectant and preparation method who contains biological products.
Background technology:
At present, be used for that the disinfectant of human body skin or mucous membrane is most to be synthetic, for example quaternary amine, chloride goods, this class disinfectant toxic and side effect is big, in the kill harmful microorganism, also can cause certain injury to human body skin, big for environment pollution in addition.
Summary of the invention:
Technical problem to be solved by this invention is the defective that overcomes above-mentioned prior art, and a kind of Disinfection Effect is good, nontoxic to human body skin, have no side effect biotype disinfectant and preparation method are provided.
The present invention solves the problems of the technologies described above by following technical scheme.It is characterized in that it is to constitute with following weight percentages: lactoferrin is 0.1%~1%, and hibitane is 0.001%~0.01%, and all the other are distilled water; Its preparation method is: get 0.1%~1% lactoferrin, and the adding distil water dissolving, other gets 0.001%~0.01% hibitane, the adding distil water dissolving, two liquid mix promptly.
The present invention passes through to add the Bio-engineering Products lactoferrin, thereby the concentration of hibitane is descended greatly, has reduced the side effect to human body skin, and because the synergy of hibitane and lactoferrin, antimicrobial effect is strengthened greatly.
Embodiment:
At present, along with the develop rapidly of biotechnology, have that various biological products are manufactured to come out.The Bio-engineering Products lactoferrin is the important component in the human milk, be that molecular weight is the glycoprotein of 78 kilodaltons, it is a member in the transferrins family, other member who belongs to transferrins has structural homology highly, the monomer glycoprotein that all has an about 80kD of big molecular group is made up of in conjunction with leaf (or zone) the iron of two repetitions.Although yet their structure is closely similar, lactoferrin demonstrates stronger IBC, particularly lactoferrin can keep iron in a wider pH scope and the performance combination stability that taps a blast furnace, and this is the key property of lactoferrin iron in conjunction with function.
Because the unique texture of lactoferrin, thus show antibacterial action, and can prophylaxis of microbial infect.Lactoferrin has three kinds of different mechanism of action to bacterium, and the first, the bacteriostasis of lactoferrin, this height iron binding affinity with it is relevant, and it can make bacterium lose the basic nutrient iron of required growth, stops biomembranous formation; The second, the bactericidal action of lactoferrin, it directly plays bactericidal action by lactoferrin N-terminal strong cation sterilization zone; The 3rd, lactoferrin can also be replied and brings into play antimicrobial acivity except being had antibacterial and bactericidal action by regulating general immunity.
In addition, because lactoferrin is to the high-affinity of iron, thereby make the living environment iron deficiency of bacterium, bacterium enters the environment that a kind of mobile status (this state can make them seek environment preferably) is replied certain nutritional deficiency by conversion, the immune defense that when bacterium is moved, is vulnerable to the host attack and the attack of other material (as antimicrobial agents, disinfectants etc.), this is with other medicines synergistic effect basis to take place.
It is the biguanides disinfectant that hibitane has another name called chlorhexidine, is a kind of toxicity, the safe disinfection agent that corrosivity and excitant are all very low.Can be widely used in the sterilization of skin and mucosa, the surface of a wound and urinary organ.
The present invention is by the mechanism of action and the physio-biochemical characteristics of the above-mentioned two kinds of materials of research, a kind of biotype disinfectant has been proposed, described this biotype disinfectant comprises lactoferrin, two kinds of compositions of hibitane, wherein lactoferrin concentration is between 0.1%~1%, and it is to make by gene engineering, and hibitane concentration is between 0.001%~0.01%, far below 0.01%~0.1% concentration in the prior art, solvent is a distilled water, has further reduced the toxicity of its preparation, uses safer.
Its preparation method is: get 0.1%~1% lactoferrin, and the adding distil water dissolving, other gets 0.001%~0.01 hibitane, the adding distil water dissolving, two liquid mix promptly.
The present invention all has more powerful killing action to all kinds of pathogenic microorganisms such as bacterium, mould, trichomonad, conveyor screws.Results of pharmacodynamic test shows that effect of the present invention 2 minutes is respectively 99.96% and 99.94% to staphylococcus aureus, colibacillary killing rate; Effect of the present invention 5 minutes is 99.73% to the oidiomycetic killing rate of white.Toxicity test through every standard, comprise skin irritatin test (average integral=0.0), mucomembranous irritant test (stimulation index=0.0), marrow polychromatic erythrocyte micronucleus test (opinion) to the micronucleus effect, cumulative toxicity test (cumulative coefficient>5*, annotate *: cumulative coefficient is big more, safety is high more, 5 is the peak of this test) or the like, every test index is all qualified.

Claims (2)

1, a kind of biotype disinfectant is characterized in that it is to constitute with following weight percentages:
Lactoferrin is 0.1%~1%, and hibitane is 0.001%~0.01%, and all the other are distilled water.
2, a kind of preparation method of biotype disinfectant is characterized in that: get 0.1%~1% lactoferrin, and the adding distil water dissolving, other gets 0.001%~0.01% hibitane, the adding distil water dissolving, two liquid mix promptly.
CNB200410022896XA 2004-02-16 2004-02-16 Biological disinfectant Expired - Fee Related CN1292659C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200410022896XA CN1292659C (en) 2004-02-16 2004-02-16 Biological disinfectant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200410022896XA CN1292659C (en) 2004-02-16 2004-02-16 Biological disinfectant

Publications (2)

Publication Number Publication Date
CN1559218A CN1559218A (en) 2005-01-05
CN1292659C true CN1292659C (en) 2007-01-03

Family

ID=34440998

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200410022896XA Expired - Fee Related CN1292659C (en) 2004-02-16 2004-02-16 Biological disinfectant

Country Status (1)

Country Link
CN (1) CN1292659C (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130020A (en) * 1995-09-05 1996-09-04 陕西咸阳达康消毒产品有限责任公司 Sterilizing liquid
CN1265007A (en) * 1998-05-28 2000-08-30 曼德勒转化有限公司 Disinfectant compsn.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130020A (en) * 1995-09-05 1996-09-04 陕西咸阳达康消毒产品有限责任公司 Sterilizing liquid
CN1265007A (en) * 1998-05-28 2000-08-30 曼德勒转化有限公司 Disinfectant compsn.

Also Published As

Publication number Publication date
CN1559218A (en) 2005-01-05

Similar Documents

Publication Publication Date Title
CN1918999A (en) Preparation process of nano antibacterial agent
CN105694229B (en) A kind of PP antibiotic plastics and preparation method thereof
CN1374003A (en) Biological fruit and vegetable preservative
CN107669619A (en) A kind of disposable hand-wrist bones gel and preparation method thereof
CN103271091B (en) Plant bactericide containing milk protein composition
CN108684660A (en) A kind of long-acting bacteriostatic disinfectant containing plants essential oil and preparation method
CN101568257A (en) Antibacterial agent and bactericidal agent
CA2641491C (en) Method of inhibiting the growth of microorganism in aqueous systems using a composition comprising lysozyme
CN1292659C (en) Biological disinfectant
CN106380748A (en) Antibacterial toy plastic and preparation method thereof
CN1088557C (en) Persistent disinfectant and preparation process thereof
CN101028004A (en) Nano-silver antibacterial powder
CN101028534A (en) Antiseptics curing liquid for contact lens
CN112400901B (en) Bactericidal composition and application thereof
CN101926830B (en) Antibacterial agent
Bouryabaf et al. Biofilm removal and antimicrobial activities of agar hydrogel containing colloid nano-silver against Staphylococcus aureus and Salmonella typhimurium
CN101744007A (en) Disinfectant
CN108904527A (en) Composite skin sterilizing liquid composite and preparation method thereof
CN107459729A (en) A kind of antibacterial food level PVC sheet and preparation method thereof
WO2019239419A1 (en) Methanoic acid composition and it's uses thereof
CN1943359A (en) Method for preparing sterilizing and alga killing agent
JPH07101810A (en) Sterilizing composition and soap containing said composition
CN1207967C (en) Sterilizing liquid for dry washing hand
CN108728762A (en) A kind of austenite antimicrobial stainless steel having quick sterilization performance
CN113303329B (en) Disinfectant containing o-phenylphenol, preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070103

Termination date: 20160216

CF01 Termination of patent right due to non-payment of annual fee